Literature DB >> 11485977

Gene expression and in situ localization of diacylglycerol kinase isozymes in normal and infarcted rat hearts: effects of captopril treatment.

M Takeda1, Y Kagaya, J Takahashi, T Sugie, J Ohta, J Watanabe, K Shirato, H Kondo, K Goto.   

Abstract

Diacylglycerol (DG) kinase (DGK) terminates signaling from DG, which serves as an activator of protein kinase C (PKC), by converting DG to phosphatidic acid. DGK is thus regarded as an attenuator of the PKC activity. In rats, five DGK isozymes have been cloned, but little is known about their role in the heart. In this study, the spatiotemporal expression of DGK isozymes was investigated in rat hearts under a normal condition and after myocardial infarction (MI) by in situ hybridization histochemistry and immunohistochemistry. In normal left ventricular myocardium, DGKalpha, DGKepsilon, and DGKzeta mRNAs were expressed evenly throughout the myocardium, although the DGKalpha expression was very low. In infarcted hearts, the expression of DGKzeta was enhanced in the peripheral zone of the necrotic area and at the border zone 3 and 7 days after MI, and to a lesser extent in the middle layer of the granulation tissue 21 days after MI. The enhanced DGKzeta expression in the infarcted and border areas could be attributed to granulocytes and macrophages. In contrast, the expression of DGKepsilon in the infarcted and border areas was lower than that in the viable left ventricle (LV) throughout the postoperation period. Furthermore, DGKepsilon expression in the viable myocardium 21 days after MI decreased significantly compared with left ventricular myocardium in the sham-operated rats and was completely restored by treatment with captopril. Our results demonstrate that three DGK isozymes are expressed in the heart and that each isozyme might have different functional characteristics in the healing and LV remodeling after MI.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485977     DOI: 10.1161/hh1501.094185

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

1.  Diacylglycerol kinase α exacerbates cardiac injury after ischemia/reperfusion.

Authors:  Toshiki Sasaki; Tetsuro Shishido; Shinpei Kadowaki; Tatsuro Kitahara; Satoshi Suzuki; Shigehiko Katoh; Akira Funayama; Shunsuke Netsu; Tetsu Watanabe; Kaoru Goto; Yasuchika Takeishi; Isao Kubota
Journal:  Heart Vessels       Date:  2013-05-30       Impact factor: 2.037

2.  Differential regulation of diacylglycerol kinase isoform in human failing hearts.

Authors:  Olga Bilim; Tetsuro Shishido; Shuji Toyama; Satoshi Suzuki; Toshiki Sasaki; Tatsuro Kitahara; Mitsuaki Sadahiro; Yasuchika Takeishi; Isao Kubota
Journal:  J Cardiothorac Surg       Date:  2011-05-08       Impact factor: 1.637

3.  Pigment Epithelium-Derived Factor (PEDF) Improves Ischemic Cardiac Functional Reserve Through Decreasing Hypoxic Cardiomyocyte Contractility Through PEDF Receptor (PEDF-R).

Authors:  Peng Lu; Yi-Qian Zhang; Hao Zhang; Yu-Feng Li; Xiao-Yu Wang; Hao Xu; Zhi-Wei Liu; Lei Li; Hong-Yan Dong; Zhong-Ming Zhang
Journal:  J Am Heart Assoc       Date:  2016-07-13       Impact factor: 5.501

Review 4.  Diacylglycerol Kinase-ε: Properties and Biological Roles.

Authors:  Richard M Epand; Vincent So; William Jennings; Bijendra Khadka; Radhey S Gupta; Mathieu Lemaire
Journal:  Front Cell Dev Biol       Date:  2016-10-18

5.  Increase in PKCα Activity during Heart Failure Despite the Stimulation of PKCα Braking Mechanism.

Authors:  Naveed Aslam
Journal:  Int J Mol Sci       Date:  2020-04-07       Impact factor: 5.923

6.  Reorganization of Metabolism during Cardiomyogenesis Implies Time-Specific Signaling Pathway Regulation.

Authors:  María Julia Barisón; Isabela Tiemy Pereira; Anny Waloski Robert; Bruno Dallagiovanna
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

7.  Diacylglycerol kinase zeta inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus.

Authors:  Olga Bilim; Yasuchika Takeishi; Tatsuro Kitahara; Takanori Arimoto; Takeshi Niizeki; Toshiki Sasaki; Kaoru Goto; Isao Kubota
Journal:  Cardiovasc Diabetol       Date:  2008-02-04       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.